AAAAAA

   
Results: 1-9 |
Results: 9

Authors: Berry, N Ariyoshi, K Balfe, P Tedder, R Whittle, H
Citation: N. Berry et al., Sequence specificity of the human immunodeficiency virus type 2 (HIV-2) long terminal repeat U3 region in vivo allows subtyping of the principal HIV-2 viral subtypes A and B, AIDS RES H, 17(3), 2001, pp. 263-267

Authors: Smith, NA Shaw, T Berry, N Vella, C Okorafor, L Taylor, D Ainsworth, J Choudhury, A Daniels, RS El-Gadi, S Fakoya, A Moyle, G Oxford, J Tedder, R O'Shea, S de Ruiter, A Breuer, J
Citation: Na. Smith et al., Antiretroviral therapy for HIV-2 infected patients, J INFECTION, 42(2), 2001, pp. 126-133

Authors: Ariyoshi, K Jaffar, S Alabi, AS Berry, N van der Loeff, MS Sabally, S N'Gom, PT Corrah, T Tedder, R Whittle, H
Citation: K. Ariyoshi et al., Plasma RNA viral load predicts the rate of CD4 T cell decline and death inHIV-2-infected patients in West Africa, AIDS, 14(4), 2000, pp. 339-344

Authors: Clarke, JR Kaye, S Babiker, AG Hooker, MH Tedder, R Weber, JN
Citation: Jr. Clarke et al., Comparison of a point mutation assay with a line probe assay for the detection of the major mutations in the HIV-1 reverse transcriptase gene associated with reduced susceptibility to nucleoside analogues, J VIROL MET, 88(2), 2000, pp. 117-124

Authors: Aboulker, JP Babiker, AG Flandre, P Gazzard, B Loveday, C Nunn, AJ Goudsmit, J Huraux, JM van der Noorda, J Weiss, R Boucher, C Schurrman, R Brun-Vezinet, F Descamps, D Jeffries, D Tedder, R Weber, J Darbyshire, JH Reiss, P Weverling, G
Citation: Jp. Aboulker et al., An evaluation of HIV RNA and CD4 cell count as surrogates for clinical outcome, AIDS, 13(5), 1999, pp. 565-573

Authors: Babiker, AG Darbyshire, JH Gazzard, BG Hooker, MH Kitchen, V Newberry, A Peto, TE Tedder, R Weber, J Breckenridge, A Back, D Blatchford, N Gartland, M Jeffries, D Johnson, M Plummer, K Wills, B Loveday, C Weller, IVD Withnall, R
Citation: Ag. Babiker et al., A randomized trial comparing regimens of four reverse transcriptase inhibitors given together or cyclically in HIV-1 infection - The Quattro Trial, AIDS, 13(16), 1999, pp. 2209-2217

Authors: Aboulker, JP Babiker, AG Brun-Vezinet, F Darbyshire, JH Flandre, P Gazzard, B Nunn, AJ Goodall, R Aber, V Bragman, K Breckenridge, AM Carbon, C Charreau, I Chene, G Collis, P Cooper, D Dormont, J Fiddian, P Flepp, M Goebel, FD Hooker, M Lange, J Luthy, R Peto, TEA Reiss, P Seligmann, M Stone, AB Thomis, J Vella, S Walckenaer, G Warrell, D Weller, IVD Wilber, R Yeni, P Yeo, J Withnall, R Goudsmit, J Huraux, JM van der Noorda, J Weiss, R Boucher, C Schuurman, R Descamps, D Jeffries, D Tedder, R Weber, J Krzyanowski, C Weverling, G
Citation: Jp. Aboulker et al., HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study, AIDS, 13(1), 1999, pp. 57-65

Authors: Farrington, M Tedder, R Kibbler, C Wreghitt, T Gould, K Tremlett, CH
Citation: M. Farrington et al., Pre-transplantation testing: who, when and why?, J HOSP INF, 43, 1999, pp. S243-S252

Authors: Ariyoshi, K Cham, F Berry, N Harding, E Sabally, S N'Gom, PT Ishikawa, K Corrah, T Tedder, R Whittle, H
Citation: K. Ariyoshi et al., Diagnosis of HIV-1/2 dual infection using dilution analysis of type-specific antibody, AIDS, 12(18), 1998, pp. 2504-2505
Risultati: 1-9 |